Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...

A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...

Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...

New three-year follow-up results from the TRANSCEND FL trial show that patients with relapsed or refractory follicular ...

A novel computational tool has been used to identify a metabolic weakness in acute myeloid leukemia, offering a new drug ...

A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...

A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...

A chemotherapy-free regimen significantly improved outcomes compared with standard therapy for newly diagnosed Ph+ acute ...

A large Mayo Clinic study shows that current guidelines fail to detect nearly 90% of people with familial hypercholesterolemia, a common inherited cause of dangerously high cholesterol. Many affected ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

The market offers significant opportunities in non-invasive cancer diagnostics using in vitro blood tests, with potential to replace traditional biopsies. Key areas include screening, diagnosis, ...

Natera has acquired Foresight Diagnostics, a business known for its ultrasensitive MRD detection, in an all-stock transaction ...